Earnings Release • Sep 5, 2017
Earnings Release
Open in ViewerOpens in native device viewer
| Informazione Regolamentata n. 0481-42-2017 |
Data/Ora Ricezione 05 Settembre 2017 15:59:43 |
MTA - Star | ||
|---|---|---|---|---|
| Societa' | : | El.En. | ||
| Identificativo Informazione Regolamentata |
: | 93454 | ||
| Nome utilizzatore | : | ELENN01 - Romagnoli | ||
| Tipologia | : | REGEM; 3.1; 1.2 | ||
| Data/Ora Ricezione | : | 05 Settembre 2017 15:59:43 | ||
| Data/Ora Inizio Diffusione presunta |
: | 05 Settembre 2017 15:59:44 | ||
| Oggetto | : | 2017 six months financial report | The Bod of El.En. releases consolidated | |
| Testo del comunicato |
Vedi allegato.
1.2 3.1 REGEM
press release
Record Consolidate Revenue at 142,9 million of euro (up 18,9%) Margins in line with H1 2016 Strong Net Financial Position at over 67 million of euro Revenue growth exceeding 10% confirmed for 2017
Florence, September 5th 2017 – The Board of Directors of El.En. SpA, leader on the laser market and listed on the STAR Segment of the Italian Stock Exchange, released today the six months consolidated financial report as of June 30, 2017.
The El.En. Group continued along its strong growth path as in the recent years, reaching record consolidated sales of 142.9 million euro (+18.9% compared to H1 2016). The industrial laser system business showed the strongest acceleration in sales, with growth exceeding 50% over the first half of 2016, thanks in first place to the performance of Chinese joint ventures - which doubled the sales compared to the first half of last year - but also to the excellent performance of the Italian based companies operating in industrial market. At this time when a technological breakthrough is accompanied by the gradual recovery of markets, the Group is currently enjoying the benefits of its strategic position on the Chinese market and of the reorganization of laser cutting operations on Italian and European markets.
EBITDA reached 15,5 million of euro, in line with the previous record year and improving 1Q 2017's performance. EBIT was 13,1 million of euro, 9,2% on revenues, slightly down from the 13,5 million of euro of the same period of 2016, due to the sales mix which includes a larger share of sales in the industrial market.
Gabriele Clementi, President di El.En. Spa said: "We feel deeply pleased with the results achieved in this semester. Backed by good growth prospects in the markets where we operate, we are able to gain market share and jointly create new niches through innovation; the ability to create and propose innovative products that enable new applications, is in fact the main critical success factor in our markets and one of El.En.'s strongest competitive weapon since its foundation. The
positive trend in sales - Gabriele Clementi continued - highlights an overall favorable market situation and we are confident that we will take advantage of the growth opportunities both in the medical and industrial fields. In addition, I would like to emphasize that we are putting in place several organizational actions, creating new vital functions for the pursuit of growth, in order to fully grasp these opportunities."
In the industrial applications segment the revenues growth rate was extremely high (up 51% vs H1 2016) due laser cutting business and the Chinese joint venture, but also to the excellent performance in the laser marking systems and laser sources where the systems bearing Lasit, Ot-Las and El.En. enjoyed an increasing success on a market in clear recovery.
Sales performance trend in medical applications sector was good, too: supported by a strong demand and a product range always tailored to customers' demands, all segments of the aesthetic sector have maintained a brilliant trend, led by hair removal, tattoo removal and skin rejuvenation, urological surgery and physiotherapy. The overall growth of the segment is the result of the brilliant aesthetic trend, up by more than 20%, and the decline in surgical applications and service, down respectively by 25% and 13%.
In terms of sales by geographic area, in the first half of 2017 rapid growth was achieved in all the relevant geographic areas, with a more significant growth in Italy (+ 25%), followed by other European markets (+ 13%) and the rest of the world ( + 19%). Italy accounts for about 20% of total sales, an important market in both the industrial and medical sectors, whose success goes far beyond the effects of the significant benefit deriving from the tax incentives provided under the name of "Industry 4.0".
Gross Margin for 1H 2017 was 59,5 million of euro, up 11.7% versus 53.3 million as of 30 June 2016, thanks to the increase in turnover. Margin on sales decreased to 41.7% from 44.3% in the first half of 2016, mostly due to the change in the sales mix.
EBITDA was a 15.5 million of euro, substantially unchanged compared to the 15.6 million euro at the 1H 2016 euro. EBITDA's stability in the presence of an increase in revenue is essentially due to the reduction in sales margins: staff and structure costs, especially the first ones, showed an increase that was however maintained within the percentage of revenue growth.
Similar considerations apply to EBIT, which showed a positive balance of 13.1 million euro, down slightly (-2.9%) compared to the 13.5 million euro of 1H 2016.
Pre-tax profit had a positive balance of 10.9 million euro (36.0 million euro at 30 June 2016); we recall that in the previous year, income benefited of approximately 23 million euros gain on the sale of 998,628 shares of Cynosure Inc. (Nasdaq CYNO).
Net income of the Group for the first half of the year was 6 million euros versus 30.3 million euro in the first half of 2016. Tax rate was approximately 26%, well above the 13% of the same period of the previous fiscal year (the tax burden as of 30 June 2016 was relieved by the so-called "PEX" on the gain on the sale of Cynosure shares).
The Group's Net financial position remained positive for 66,8 million euro compared to 82,8 million euro as of December 31, 2016. The use of cash of the period was mainly determined by the increase in net working capital, increased as an effect of the rapid growth of the Group, particularly
in China. In addition, during the first half of the year, dividends were paid to third parties for a total of 8,4 million euro.
The results for the first half of the year 2017 were in line with the guidance the Group disclosed to the market for the year. The favorable phase of our main markets, and in particular the rapidly developing industrial sector, leads the Group's revenue growth in the six months well over 10%, a threshold that we confirm to be able to exceed on an annual basis, too. For what concerns EBIT, the trend in the mix of products sold and the intensification of certain cost items, in the pursue of future growth, currently confirm the 2016 EBIT as the objective for the year 2017.
***********
The manager in charge of preparing the corporate accounting records, Enrico Romagnoli, declares, pursuant to paragraph 2, article 154-bis of the Consolidated Finance Law, that the accounting disclosures provided in this document correspond to the accounting records, books and entries.
As required by Consob, the Half yearly report as of June 30th, 2017 will be available for the public at our premises in Calenzano, at Borsa Italiana SpA, on our website www.elengroup.com from September 5th, 2017 in section "Investor Relations / Documenti Finanziari / Relazioni e Bilanci / 2017" and on authorized storage website .
***********
On Thursday, September 7th, 2017 at 15:00 CET (14:00 GMT) (9:00 EST), EL.EN. Spa will hold a conference call with the financial community, to discuss the financial results of the Group. You can dial the following numbers: from Italy +39 02 8058811, from UK +44 121 2818003, from USA +1 718 7058794. Before the conference call, you can download the presentation slides from the Investor Relations page of the El.En. website : http://www.elengroup.com/it/investorrelations/presentazioni
***********
El.En., an Italian company, is the parent of a high-.tech industrial group operating in the optoelectronics sector. Based on proprietary technology and multidisciplinary know-how, the El.En Group manufactures laser sources (gas, semiconductor, solid-state and liquid) and innovative laser systems for medical and industrial applications. The El.En. Group is the laser market leader in Italy and among the top operators in Europe. It designs, manufactures and sells worldwide:
- Medical laser equipment used in dermatology, cosmetics, physiotherapy, dentistry and gynecology;
- Industrial laser systems for applications ranging from cutting, marking and welding metals, wood, plastic and glass to decorating leather and textiles and restoring/conserving artwork;
- Laser systems for scientific research
EL.EN has been listed on the Star (MTA) of Borsa Italiana. Its market floatation is approximately 41% and its market capitalization amounts to Euro 480 million.
Cod. ISIN: IT0005188336 Sigla: ELN Listed on MTA Mkt cap.: 480 million of euro Cod. Reuters: ELN.MI Cod. Bloomberg: ELN IM
For further information:
Investor Relations Enrico ROMAGNOLI - [email protected] Tel. +39 055 8826807
Financial Communication, IR and Press Office Bianca FERSINI MASTELLONI - [email protected] Simona D'AGOSTINO - [email protected] Silvia MARONGIU - [email protected] Tel. +39 06-69923324
| Income Statement | 30/06/2017 | Inc % | 30/06/2016 | Inc % | Var. % |
|---|---|---|---|---|---|
| Revenues | 142.877 | 100,0% | 120.176 | 100,0% | 18,89% |
| Change in inventory of finished goods and WIP | 5.208 | 3,6% | 907 | 0,8% | 474,27% |
| Other revenues and income | 1.661 | 1,2% | 1.869 | 1,6% | -11,12% |
| Value of production | 149.746 | 104,8% | 122.951 | 102,3% | 21,79% |
| Purchase of raw materials | 79.766 | 55,8% | 62.332 | 51,9% | 27,97% |
| Change in inventory of raw material | (237) | -0,2% | (2.463) | -2,0% | -90,39% |
| Other direct services | 10.708 | 7,5% | 9.818 | 8,2% | 9,07% |
| Gross margin | 59.509 | 41,7% | 53.264 | 44,3% | 11,72% |
| Other operating services and charges | 17.977 | 12,6% | 15.446 | 12,9% | 16,38% |
| Added value | 41.532 | 29,1% | 37.818 | 31,5% | 9,82% |
| Staff cost | 26.062 | 18,2% | 22.251 | 18,5% | 17,13% |
| EBITDA | 15.469 | 10,8% | 15.567 | 13,0% | -0,63% |
| Depreciation, amortization and other accruals | 2.335 | 1,6% | 2.043 | 1,7% | 14,30% |
| EBIT | 13.134 | 9,2% | 13.524 | 11,3% | -2,88% |
| Net financial income (charges) | (2.204) | -1,5% | (464) | -0,4% | 374,81% |
| Share of profit of associated companies | (49) | 0,0% | (100) | -0,1% | -50,84% |
| Other non-operating income (charges) | 0 | 0,0% | 23.019 | 19,2% | -100,00% |
| Income (loss) before taxes | 10.881 | 7,6% | 35.979 | 29,9% | -69,76% |
| Income taxes | 2.824 | 2,0% | 4.656 | 3,9% | -39,35% |
| Income (loss) for the financial period | 8.057 | 5,6% | 31.323 | 26,1% | -74,28% |
| Net profit (loss) of minority interest | 2.047 | 1,4% | 1.029 | 0,9% | 98,86% |
| Net income (loss) | 6.010 | 4,2% | 30.293 | 25,2% | -80,16% |
| Statement of financial position | 30/06/2017 | 31/12/2016 | Variation |
|---|---|---|---|
| Intangible assets | 4.096 | 3.896 | 200 |
| Tangible assets | 38.186 | 39.616 | -1.431 |
| Equity investments | 3.600 | 3.818 | -218 |
| Deferred tax assets | 6.702 | 6.526 | 176 |
| Other non current assets | 11.979 | 10.881 | 1.097 |
| Total non current assets | 64.562 | 64.737 | -175 |
| Inventories | 66.492 | 62.138 | 4.354 |
| Accounts receivable | 71.427 | 62.446 | 8.981 |
| Tax receivables | 6.341 | 5.213 | 1.128 |
| Other receivables | 8.657 | 8.564 | 93 |
| Financial instruments | 499 | 0 | 499 |
| Cash and cash equivalents | 81.932 | 97.589 | -15.657 |
| Total current assets | 235.348 | 235.950 | -602 |
| Total Assets | 299.910 | 300.687 | -777 |
| Share capital | 2.509 | 2.509 | 0 |
| Additional paid in capital | 38.594 | 38.594 | 0 |
| Treasury stock | 0 | 0 | 0 |
| Other reserves | 98.095 | 64.137 | 33.958 |
| Retained earnings / (accumulated deficit) | 35.115 | 36.188 | -1.072 |
| Net income / (loss) | 6.010 | 40.408 | -34.398 |
| Group shareholders' equity | 180.323 | 181.835 | -1.512 |
| Minority interest | 11.808 | 10.864 | 944 |
| Total shareholders' equity | 192.131 | 192.699 | -568 |
| Severance indemnity | 3.951 | 3.861 | 91 |
| Deferred tax liabilities | 1.314 | 1.607 | -293 |
| Reserve for risks and charges | 3.591 | 3.514 | 77 |
| Financial debts and liabilities | 6.561 | 4.342 | 2.218 |
| Total non current liabilities | 15.417 | 13.324 | 2.093 |
| Financial liabilities | 9.237 | 10.613 | -1.376 |
| Accounts payable | 41.994 | 44.694 | -2.700 |
| Income tax payables | 2.391 | 4.285 | -1.894 |
| Other current payables | 38.741 | 35.072 | 3.669 |
| Total current liabilities | 92.363 | 94.664 | -2.301 |
| Total Liabilities and Shareholders' equity | 299.910 | 300.687 | -777 |
| Cash Flow Statement | 30/06/2017 | 30/06/2016 |
|---|---|---|
| 0 | ||
| Cash flow generated by operating activity: | ||
| Profit (loss) for the financial period | 8.057 | 31.323 |
| 0 | ||
| Amortizations and depreciations | 1.911 | 1.609 |
| Gain on investment AFS | -23.018 | |
| Share of profit of associated companies | 49 | 100 |
| Stock Option | 431 | |
| Change of employee severance indemnity | 91 | 551 |
| Change of provisions for risks and charges | 77 | 460 |
| Change of provisions for deferred income tax assets | -176 | -458 |
| Change of provisions for deferred income tax liabilities | -293 | -206 |
| Inventory | -4.354 | -3.298 |
| Accounts receivable | -8.981 | -52 |
| Tax receivables | -1.128 | 1.132 |
| Other receivables | -414 | -494 |
| Accounts payable | -2.700 | -1.501 |
| Income Tax payables | -1.894 | 35 |
| Other payables | 3.669 | 4.715 |
| 0 | ||
| 0 | -13.712 | -20.427 |
| 0 | ||
| Cash flow generated by operating activity | -5.655 | 10.896 |
| Cash flow generated by investment activity: | ||
| (Increase) decrease in tangible assets | -352 | -4.073 |
| (Increase) decrease in intangible assets | -328 | -222 |
| (Increase) decrease in equity investments and non current assets | -929 | 40.018 |
| Increase (decrease) in financial receivables | 321 | 120 |
| (Increase) decrease current investments | -499 | -51 |
| 0 | ||
| Cash flow generated by investment activity | -1.787 | 35.792 |
| 0 | ||
| Cash flow from financing activity: | ||
| Increase (decrease) in non current financial liabilities | 2.218 | -553 |
| Increase (decrease) in current financial liabilities | -1.376 | -4.666 |
| Dividends paid | -8.479 | -6.384 |
| 0 | ||
| Cash flow from financing activity | -7.637 | -11.603 |
| 0 | ||
| Change in cumulative conversion adjustment reserve and other | -578 | 749 |
| no monetary changes | ||
| Increase (decrease) in cash and cash equivalents | -15.657 | 35.835 |
| Cash and cash equivalents at the beginning of the financial period | 97.589 | 46.990 |
| 0 | ||
| Cash and cash equivalents at the end of the financial period | 81.932 | 82.825 |
The El.En. Group uses some alternative performance indicators that are not identified as IFRS accounting measures, in order to better assess the Group's performance. Therefore criteria of determination applied by the group may not be homogeneous with that adopted by other groups and the value obtained may not be comparable.
These alternative performance indicators, determined in accordance with the Guidelines on Alternative Performance Indicators issued by ESMA / 2015/1415 and adopted by CONSOB with communication no. 92543 of December 3, 2015, refer only to the performance of the accounting period covered by this release and the periods to be compared.
The Group uses the following alternative performance indicators to evaluate the financial performance:
The Group uses as alternative performance indicators to evaluate their ability to cope with financial obligations:
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.